T F Delaney - JoVE Visualize

Showing results (31-40 of 41) with videos related to

Pageof 5

Sort By:

Lasers in Surgery and Medicine|January 1, 1994

Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early clinical experienceZ A Tochner, H I Pass, P D Smith, et al.

Journal of Clinical Laser Medicine & Surgery|October 1, 1991

A light-diffusing device for intraoperative photodynamic therapy in the peritoneal or pleural cavityT F DeLaney, P D Smith, G F Thomas, et al.

Sarcoma|May 24, 2012

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330J M Kane, J Harris, W G Kraybill, et al.

Annals of Surgical Oncology|January 1, 1994

Intrapleural photodynamic therapy: results of a phase I trialH I Pass, T F DeLaney, Z Tochner, et al.

International Journal of Radiation Oncology, Biology, Physics|November 1, 1991

Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcomaS F Stinson, T F DeLaney, J Greenberg, et al.

Cancer|August 15, 1996

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumorsL H Wexler, T F DeLaney, M Tsokos, et al.

Journal of Pediatric Hematology/Oncology|May 1, 1995

A phase I and II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumorsT G Abrahamsen, B J Lange, R J Packer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomasJ F Kuttesch, L H Wexler, R B Marcus, et al.

Urology|August 1, 1997

Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladderM M Walther, T F Delaney, P D Smith, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.

Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:

Pageof 5

Lasers in Surgery and Medicine|January 1, 1994

Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early clinical experienceZ A Tochner, H I Pass, P D Smith, et al.

Journal of Clinical Laser Medicine & Surgery|October 1, 1991

A light-diffusing device for intraoperative photodynamic therapy in the peritoneal or pleural cavityT F DeLaney, P D Smith, G F Thomas, et al.

Sarcoma|May 24, 2012

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330J M Kane, J Harris, W G Kraybill, et al.

Annals of Surgical Oncology|January 1, 1994

Intrapleural photodynamic therapy: results of a phase I trialH I Pass, T F DeLaney, Z Tochner, et al.

International Journal of Radiation Oncology, Biology, Physics|November 1, 1991

Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcomaS F Stinson, T F DeLaney, J Greenberg, et al.

Cancer|August 15, 1996

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumorsL H Wexler, T F DeLaney, M Tsokos, et al.

Journal of Pediatric Hematology/Oncology|May 1, 1995

A phase I and II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumorsT G Abrahamsen, B J Lange, R J Packer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomasJ F Kuttesch, L H Wexler, R B Marcus, et al.

Urology|August 1, 1997

Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladderM M Walther, T F Delaney, P D Smith, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.

Pageof 5